NCT04443712 is a clinical trial in Coronavirus Disease 2019 (COVID19), sponsored by Samia Girgis.

Who is sponsoring NCT04443712?

NCT04443712 is sponsored by Samia Girgis.

What condition does NCT04443712 study?

NCT04443712 studies Coronavirus Disease 2019 (COVID19).

Is NCT04443712 still recruiting?

NCT04443712 is currently status unknown. Last updated 23 June 2020.

Last reviewed 2020-06-23 · How we verify

NCT04443712

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)

Status unknown Last updated 23 June 2020

What this trial tests

trial in Coronavirus Disease 2019 (COVID19) in 1,900 participants. Status unknown.

Timeline

29 May 2020

Primary endpoint
1 June 2021

1 December 2021

Quick facts

Lead sponsor	Samia Girgis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,900
Start date	29 May 2020
Primary completion	1 June 2021
Estimated completion	1 December 2021
Sites	1 location across Egypt

Conditions studied

Coronavirus Disease 2019 (COVID19) — all drugs for Coronavirus Disease 2019 (COVID19) →

Sponsor

Samia Girgis

Who can join

Eligibility, any sex, with Coronavirus Disease 2019 (COVID19). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to screen the patients seeking hospitalization in Ain Shams university hospitals and identify a cost effective tool for continuing screening the patients all through the epidemic period

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04443712 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samia Girgis
Last refreshed: 23 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04443712.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing